CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- S-3 Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Director sold 350 shares at $16.95 ($5,933)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 4 Gift Chief Executive Officer gave 189,103 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- D/A Other Amended Notice of Exempt Offering of Securities
- 4 Planned sale Director sold 350 shares at $15.68 ($5,488)
- 4 Option exercise Director acquired 5,061 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,079 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 9 of 28 · 542 filings